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In the event of a radiological attack on a civilian population, there will be a need 
to screen a large number of people for contamination in a timely and effective manner.  
With the increasing presence of nuclear medicine departments in local hospitals, a variety 
of radiation detection and imaging systems will exist that could be used to evaluate 
incoming patients.  Utilizing the Monte Carlo N-Particle  radiation transport code version 
5 (MCNP5), developed by Los Alamos National Laboratory, the feasibility of using a 
thyroid uptake counter for detecting lung contamination has been investigated.   
A variety of MCNP models were first created to validate the detector model and 
code simulations against measured data obtained from a preliminary study.  
Measurements were previously made by S. Cohen & Associates, Inc. (SC&A) with 
discrete, encapsulated sources of 60Co, 137Cs, 192Ir and 241Am in an acrylic slab phantom 
and in air, with the source and detector system placed various distances apart.  An 
additional setup was used to measure the count rates from a 131I source uniformly 
distributed in a water-filled phantom. 
 The comparison of the MCNP simulations with the measurements provided the 
validation required to perform calculations with the code for source and detector 
geometries beyond those for which measurements are available.  Anthropomorphic 
phantoms of various ages, sexes, and body masses were modeled to simulate variations in 
radioactive material distributions in the lungs as well as the change in detection 
efficiency due to the varying thicknesses of intervening tissue.  The minimum detectable 
activity was calculated for each setup and retention fractions were used to establish the 
  ix
amount of material expected to remain in the body shortly after intake.  Dose correlations 
were used to quantify the energy that would be deposited by the inhaled radioactive 
material and both collimated and uncollimated detector geometries were analyzed to fully 






 In a recent survey of some of the nation’s leading experts, the probability of an 
attack from a weapon of mass destruction (WMD) is as high as 50 percent over the next 
five years with the most significant risk of attack expected to come from a radiological 
dispersal device (RDD) (Lugar, 2005).  These devices may be implemented in a number 
of different forms, each having the ability to spread radioactive isotopes over a large area.  
If an RDD event were to take place in a metropolitan area, the result would be a large 
number of people ingesting or inhaling radioactive material.   
Some of these materials may ultimately concentrate in various organs of the body 
or be distributed uniformly through the entire body over time.   However, for at least a 
brief period after inhalation, a portion of the radioactive material will be concentrated in 
the lungs until cleared by the respiratory tract or absorbed into the bloodstream (Jarret et 
al., 2003).  The ability to screen large numbers of people who may be internally 
contaminated with radioactive materials will be necessary so that medical intervention 
can be employed if needed. 
 The device typically used to monitor internal radioactivity in a person is known as 
a whole-body counter (WBC) and can be found at most large nuclear facilities.  This 
system employs a radiation detector or a set of detectors outside of the body to measure 
radiations emitted by the materials deposited inside the body.  The energy distributions of 
the measured radiation can also be used to assist in identifying the material present as 
well as assist in quantifying it.  WBCs, however, are not readily available in metropolitan 
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areas because most nuclear facilities where internal contamination is of concern are 
somewhat removed from large population centers.   
 SC&A, Inc. has undertaken an evaluation for the Centers for Disease Control and 
Prevention (CDC) to analyze the use of more readily available radiation detection 
systems, such as those used in nuclear medicine procedures, to perform whole-body 
counting after RDD events (Anigstein et al., 2005).  These systems, although not 
optimized for whole-body counting, are still potentially useful in determining even low 
body burdens of radioactive material; at least low enough to assess victims for triage.  Of 
particular interest are those detection systems found in nuclear medicine departments at 
most hospitals.  These instruments include nuclear medicine cameras and thyroid uptake 
probes.  A variety of other systems that are used for assaying hospital waste streams and 
surveying for radioactive contamination are also being considered in the SC&A study.  
These systems detect radiation external to the body from radioactive materials deposited 
in the body by utilizing effective scanning procedures. 
 This thesis extends the work performed by SC&A for the use of a thyroid uptake 
system for monitoring lung contamination.  Most of their measurements used point 
sources of radiation to represent material inhaled from RDD events when in actuality the 
radioactivity is not likely to be concentrated in a single location.  Another aspect of their 
study simulated the distributed loadings of a radioactive source in a lung by dissolving a 
radioactive substance in a water phantom.  Although this source distribution is more 
representative of an expected inhalation model, it uses a different density composition 
than lung, tissue, and bone and greatly simplifies the geometry of a human torso. 
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 To exhaustively study the performance of this detection system by a measurement 
program would be very time intensive and costly.  Instead, through the use of the highly 
validated MCNP Monte Carlo radiation transport code, simulations were carried out to 
address the response of the thyroid uptake counter to diffuse sources in human phantoms 
and the variation of the minimum detectable activity (MDA) levels in the lungs as a 
function of intervening tissue thickness.  Models were also developed to include 





     
 There are a variety of systems and methods that are specifically designed for the 
detection of internally deposited radioactivity.  After an RDD event, the availability and 
access to these technologies will be limited but an understanding of these detection 
systems for internal counting and their relationship to other detection systems is of value.  
In this section, some general aspects of internal contamination assessment and gamma-
ray interactions important to spectroscopy and detection are discussed.  
2.1 Internal Contamination Assessment 
 The methods for quantifying the amount of radioactivity present in an individual 
may be divided into two categories, namely in vitro and in vivo bioassays.  For in vitro 
bioassay, the radioactivity of material excreted from the body is measured and compared 
to the expected intake of radioactivity for the person in consideration.  The remaining 
activity in the body can then be estimated from this information and knowledge of the 
metabolism of the material in the human body.  The in vivo method utilizes external 
counting equipment, such as WBCs, to detect photon radiations that are directly emitted 
from the body.  The amount of radioactive material present can then be inferred from the 
knowledge of the source material, the migration of the radionuclide in the body, the 
physical detector placement, and the characteristics of the detection system.  In an RDD 
event involving the public, a timely response is of the utmost concern.  Therefore, the in 
vivo bioassay method will be the most effective in triaging victims for internal 
contamination of high enough levels to be of concern. 
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 As mentioned previously, the only radionuclides of importance to external 
detection are those that emit photons (x-rays, γ-rays or bremsstrahlung radiation) or beta 
particles of sufficient energy to penetrate the layers of tissue typical of the human body.  
Once these particles escape the surface, there are a variety of whole-body or specific-
organ counters that are commonly used in radiation protection and nuclear medicine that 
can determine the quantity and location of radioactive material in the body.  WBC 
systems have routinely been used to monitor individuals who are commonly exposed to 
unsealed radioactive sources in the workplace.  These systems can also be used to 
determine previous intakes of radionuclides using metabolic models that describe the 
behavior of the substance in the body.  Similar techniques are used in some diagnostic 
medical procedures as well; an example is the thyroid probe which is used to measure the 
uptake of radioactive iodine in the treatment of hyperthyroidism. 
 These instruments and procedures have greatly improved over the years.  The first 
measurements of radionuclides deposited in the body were performed on the radium dial 
painters in the mid-to-late 1920s.  It was common during this period for the workers to 
lick the tips of their paint brushes, resulting in the ingestion of small amounts of radium 
each time.  Schlundt and his associates were able to make rudimentary measurements 
regarding the amount of internally deposited radium by utilizing an electroscope 
positioned along the spine of a contaminated patient (Schlundt et al., 1929).  In addition 
to performing such basic measurements, these early researchers developed techniques 
that could be used when monitoring internal radioactivity to provide a standard for future 
studies (Flinn, 1929), many of which are applicable to today’s detection systems. 
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   Once nuclear research spread to military and civilian sectors, the desire to limit 
internal radiation exposure to workers became a greater concern and led to the 
development of detection systems and techniques for that purpose.  Prior to the mid-
1950s, it was common to find that “in vitro bioassay was the only method available to 
assess occupational intakes of radionuclides in defense facilities” (Taylor, 2000).  
However, shortly thereafter, the continued development of solid scintillation and 
semiconductor detectors enabled the detection of radioactive emissions from areas of the 
body not previously covered in external bioassay techniques.   
 One of the most notable developments was the thallium-activated sodium iodide 
(NaI[Tl]) crystal.  The high light yield produced in this material by ionizing radiation and 
the ability to shape these crystals into detectors of large diameter gave them an advantage 
in γ-ray detection efficiency over other systems.  A variety of WBCs began to employ 
this technology in facilities that utilized both chair and flat-bed setups to monitor 
contaminated subjects.  In addition, heavily shielded rooms were implemented to reduce 
the effect of background radiation on the number of counts registered by the detection 
systems (Taylor, 2000).  
 Thin sodium iodide crystals were also being implemented in low energy photon 
detection, but problems resulting from the fragility of the crystal and their high cost led to 
the development of other detectors for chest counting.  One such development was the 
Phoswich detector, a thin NaI crystal sandwiched with a cesium iodide (CsI) crystal, that 
can be used to measure both high and low energy photons (Hickman, 1994).  Further 
advances were made in in vivo counting with the development of high purity germanium 
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(HPGe) detectors.  This detection system is known for its increased energy resolution 
and, therefore, the ability to distinguish between γ-rays of similar energy. 
 In general, however, the ability of all of these detection systems to assay 
radioactivity in vivo has been extensively analyzed and well documented.  The minimum 
detectable activities (MDAs) attainable by these counting systems can be measured to 
less than one thousandth of the annual dose limit allowable for radiation workers.  Even 
smaller amounts of radioactivity can be determined if the material is known to be 
concentrated in specific areas, with values being measured as low as 3 pCi (Toohey et al., 
1991).   
 Detection at such a high level of sensitivity, however, would not be warranted in 
screening individuals following an RDD scenario, as indicated by the incident that 
occurred in Goiânia, Brazil in 1987.  It was in this town that an abandoned medical 
source containing 1375 Ci of 137Cs was breached, contaminating people directly and 
indirectly to internal levels that ranged from below the MDA of the WBC system utilized 
(197 nCi) up to 1.6 mCi.  Normal WBC facilities were not used due to their distance from 
the accident or because the in vivo activities were too high for the instrumentation 
(Oliveira et al., 1991).  Fortunately, only a relatively small number of people were 
affected by this incident, but lessons from this experience and an understanding of 
various in vivo detection capabilities are useful to those confronted with a similar 
situation in the future.  
2.2 Gamma-Ray Interactions 
  A variety of interaction possibilities exist as gamma rays pass through matter, but 
the most important to spectroscopy are photoelectric absorption, Compton scattering, and 
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pair production (Knoll, 2000).  In each of these processes, it should be realized that the 
photon is uncharged and consequently does not cause direct ionization in the material in 
which it is being transported.  The detection of γ-rays is dependent upon the loss of 
kinetic energy to electrons through scattering or complete absorption in the detection 
material.  
 The most likely interaction in which a γ-ray will deposit all of its energy to the 
surrounding medium is the photoelectric effect and is the predominate reaction with low 
energy gamma rays.  In this process, the incident photon interacts with a bound inner 
shell electron which is then ejected from the atom (Figure 2.1).  The energy of this 
particle is equal to that of the incident photon minus the binding energy of the 
photoelectron’s original shell.  The subsequent de-excitation of the atom results in the  
 
 
Figure 2.1:  Photoelectric Absorption 
 
emission of x-ray photons and/or Auger electrons which are stopped in a short distance 
within the material in comparison to the mean free path of the γ-rays (Arqueros et al., 
2003). 
 The Compton scattering interaction, however, is a purely kinematic collision 
between a gamma photon and a loosely bound electron in the absorbing material.  This 
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process dominates in the energy region of a few keV up to several MeV and unlike 




Figure 2.2:  Compton Scattering 
 
 Solving the energy and momentum equations for this type of collision can yield 
the energy of the recoiling electron as well as the energy of the scattered photon: 
 





E  = 
1+(E /m c )(1-cos θ)
                                    [2.2] 
 
When the scattering angle is 180º, the γ-ray is scattered backwards and the maximum 
energy is imparted to the electron.  Even at this value, however, the energy of the electron 
is still less than the incident gamma.  This indicates that for any scattering angle the 
amount of γ-ray energy absorbed by the detector in a Compton collision will be less than 
that of the incident photon. 
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 The third significant interaction to gamma spectroscopy is pair production, a 
process that can only be achieved at energies greater than 1.022 MeV, but is only 
significant for incident energies of several MeV (Keenan, 1999).  The reason for this 
energy requirement is that in this interaction, the incident γ-ray is converted into an 
electron-positron pair each with a rest mass of 0.511 MeV. 
 The positron emitted in this interaction is not a stable particle and once its kinetic 
energy is reduced to that of the surrounding material, will annihilate or combine with a 
normal electron in the absorbing medium (Knoll, 2000).  This process yields two 
annihilation photons of equal energy as illustrated in Figure 2.3. 
 
 







 Monte Carlo methods have previously been used to simulate in vivo 
measurements of radionuclides.  In particular, a variety of research has documented the 
use of Los Alamos’s MCNP code to perform WBC calibrations, various phantom 
measurements, and simulations for targeted radiotherapy (Kramer et al., 2002; Franck et 
al., 2003; Autret et al., 2005).  To evaluate the capabilities of a thyroid probe in assaying 
lung contamination, photon transport essential to radiation detection was simulated using 
MCNP5.  A set of MCNP models was first used to validate the detector performance 
against previously reported results before extending the code to source-detector 
geometries and configurations not available in the measurement program.  A summary of 
these simulations is detailed below and the section is concluded with an MDA 
formulation and an evaluation of dose coefficients applicable to these models. 
3.1 Detection System Overview 
 There are a variety of thyroid uptake systems used in nuclear medicine 
departments across the country, but each of these systems utilizes similar detection 
equipment.  The Atomlab 9501 is an example of one such system and was used in 
SC&A’s evaluation of hospital detectors as potential internal contamination monitors 
(Anigstein et al., 2005).  This system was originally designed for thyroid uptake studies, 
wipe tests, and hematology tests, but a thyroid counter has been previously cited as being 
                                                 
 
 
1 Biodex Medical Systems, Inc.  20 Ramsay Road, Shirley, New York 11967 
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“useful as an emergency whole-body counter for larger gamma exposures” (NCRP, 
1980). 
 This particular system is based on a 2” x 2” (5 cm x 5 cm) NaI(Tl) detector 
coupled to a 1024-channel multi-channel analyzer.  A cylindrical lead housing attached to 
a control arm contains the NaI crystal and photomultiplier tube.  The housing also 
contains a cone-shaped lead collimator that extends 15.2 cm from the face of the detector 
towards the subject to be assayed and has an aperture of approximately 9.2 cm.  Based on 
these dimensions and the material compositions, a MCNP model of the detector was 
created and has been utilized in a variety of scenarios (Figure 3.1).   
 
      
Figure 3.1:  Atomlab 950 (Anigstein et al., 2005) and MCNP 2-D Visualization 
 
 The radioisotopes investigated in this work are of those 80 
cited as being of the highest security concern and the most likely to be used in a 
radiological attack (Ferguson, 2003).  The majority of these sources are included in the 
pre-programmed gamma spectrometry library for the detection system.  The only source 
not in the library is 241Am, which was counted using a user-defined energy window.  
Some of the source characteristics and detection system properties used in the Monte 
Carlo modeling are presented in Table 3.1.  Many of these sources have numerous photon 
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emissions in their decay schemes, but only the principal γ-rays and their corresponding 
region of interest (ROI) have been included.  For the analysis of the 192Ir source, it should 
be noted that the gamma energy range and intensity represent six photons. 
  
Table 3.1:  Source Characteristics and Detection Properties 
Radionuclides Co-60 I-131 Cs-137 Ir-192 Am-241 
Energy (keV) 1173  1333 364.5  637 661.7 296 – 612 59.5 
γ-ray 
Intensity 1       1 0.81  0.073 0.851 2.1 0.359 
ROI (keV) 997-1533 309-420 561-761 250-703 40-73 
 
In each of the models that follow, the response of the detection system will be 
calculated using the pulse-height tally available in MCNP.  This tally summarizes the 
normalized number of photons interacting with the detector and is equivalent to the 
experimentally determined absolute efficiency of the thyroid probe, with units of counts-
per-second per photon-per-second (Kramer et al., 2000). 
3.2 Code and Model Validation 
 To ensure that the modeled detector and the MCNP code could effectively 
simulate the actual performance of the Atomlab system, a variety of simulations were 
performed for comparison with the measured data of SC&A.  These measured data sets 
included point sources of radiation in air and in various depths in an acrylic slab 






3.2.1 Point Sources in Air 
 The first measurements involved discrete, encapsulated sources of 60Co, 137Cs, 
192Ir and 241Am.  These sources were individually placed at various distances from the 
NaI crystal, ranging from the face of the collimator to a position 100 cm from the end of 
the collimator.  This setup was utilized to determine the response of the detection system 
to gamma-emitting sources that have not been greatly attenuated in a transport medium.  
The MCNP simulation of this design was modeled as exactly as possible, representing the 
small encapsulated sources as point sources. 
3.2.2 Acrylic Slab Phantom 
 Further studies were performed using an acrylic slab phantom to simulate the 
transport of photons through a material with characteristics similar to that of human 
tissue.  The slabs were composed of plastic, polymethyl-methacrylate (PMMA), with a 
typical density of 1.19 g/cm3 and chemical formula (C5O2H8)n (Anigstein et al., 2005).  A 
total of ten slabs, each approximately 29.9 cm x 29.9 cm square with a thickness of 2.4 
cm, were utilized in the original measurement program to simulate the effect of varying 
tissue thickness on the Atomlab’s detection efficiency. 
 The same sources used in the air model were also used in this study.  Each of the 
sealed sources was individually placed in an eleventh slab that had an air gap in the 
middle to hold the source.  Anigstein et al. first performed measurements with the 
collimator flush against the source slab, then additional slabs were progressively added 
between the detector and source until all of the slabs had been analyzed (Figure 3.2).    
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Figure 3.2:  Full Acrylic Slab Phantom (Anigstein et al., 2005) and MCNP Visualization 
 
 When this model was created in MCNP5, it was to mimic the measurement 
program as closely as possible.  The discrete sources, however, were again modeled as 
isotropic point sources, but an additional adjustment can be seen in Figure 3.2.  Unlike 
the setup used by SC&A, all of the slabs other than the source-holder have been modeled 
as one continuous block.  The slight separation or air gap that could exist between the 
slabs has been disregarded and is expected to have little, if any effect on simulated 
detection efficiency.  
3.2.3 Water-Filled Phantom 
 The final setup analyzed with MCNP from the SC&A measurement program was 
the distributed source in a water-filled phantom.  This design is supposed to mimic the 
expected source distribution for an inhalation model and will test the detector’s response 
as a function of distance from the center of the source phantom.  Two different 
orientations were used in this study with measurements made from both the broad and 
narrow sides of the phantom.  Measurements were made with the phantom placed a 
number of distances from the detector, extending from the collimator face to 100 cm 
from the collimator. 
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 The phantom used in the measurement program was a plastic jug with an aqueous 
solution of 131I distributed in the water volume.  The dimensions of the container were 
approximately 28 cm x 16 cm with a height of 38 cm, with the water in the system 
reaching a level of 28 cm (Erdman, 2005).  The actual setup and MCNP representations 
are illustrated below in Figures 3.3 and 3.4 respectively, with the distributed source 
visible in the simulated model. 
 
 
Figure 3.3:  Water-Filled Phantom Setup (Anigstein et al., 2005) 
 
  
Figure 3.4:  MCNP Visualization of Broad and Narrow Views of Water-Filled Phantom 
  
3.3 Human Phantom Models 
 In an effort to extend the findings of the measurement study to include designs 
more realistic of the human body, anthropomorphic phantoms of several ages and body 
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sizes were created using the software package, BodyBuilder (White Rock Science, 2004).  
The human models developed in this program are based on the Medical Internal 
Radiation Dose (MIRD) reports and are generated into a MCNP geometry format (Van 
Riper, 2004).  For the purpose of this study, phantoms representing a man, woman, 
adipose man, adipose woman and an androgynous 10-year-old child were created.  Each 
of these models has varying lung sizes and chest thicknesses and better represent the 
human body as well as some variations in the general population, than would point 
sources and acrylic slabs.  Dimensions of the phantoms are shown in Table 3.2. 
 
Table 3.2:  Human Phantom Statistics 
Chest to Lung Position (cm) 













Man 179 73.1 3380 24.0 2.8 9.3 15.8 
Woman 168 56.5 2200 20.6 3.0 9.1 15.2 
Adipose Man 179 113 3380 24.0 7.8 14.3 20.8 
Adipose 
Woman 168 89.5 2200 20.6 8.1 14.2 20.3 
Androgynous 
Child 140 32.7 1530 17.4 2.3 7.7 13.2 
  
 In these phantoms, both distributed and point sources of radiation have been 
modeled.  The sources that were analyzed were the same used in the validation models, 
which included 60Co, 131I, 137Cs, 192Ir and 241Am.  In the phantom simulations, the 
isotropic point sources were individually placed in the center of each lung and were each 
assigned the same intensity.  For the distributed source models, the starting location and 
direction of the photons are established in the lung volumes at random by the Monte 
Carlo code.  This is accomplished by enclosing the source organ in the smallest box that 
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will completely contain it and choosing points at random within the box that also lie 
within the lungs.  If the point does not lie in either of the lungs, it is rejected and another 
emission point is chosen (Stansbury, 1994).  This process is repeated until a 
predetermined number of particle histories have been simulated.  Several illustrations of 




Figure 3.5:  Human Phantom and Detector Models for Point and Distributed Sources 
 
 The physical placement of the thyroid probe can greatly influence the detection 
efficiency.  In regard to Figure 3.5, it can be seen that the collimated detection system is 
not large enough to monitor both lungs at the same time, a problem not usually 
encountered in a dedicated WBC system.  To address this issue, several preliminary 
MCNP simulations were made to determine the optimal positioning for the detector 
before fully analyzing each phantom and source distribution.   
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 In these scoping calculations, the detector was modeled at center-lung height and 
at positions on both the front and the back of the phantom.  A total of five locations were 
analyzed with the detector centered on each lung from the front, each lung from the back, 
and a fifth position on the chest, in between the two lungs.  A distributed source was used 
in each case and both collimated and uncollimated systems were simulated to examine 
the effects related to detector geometry, even though the Atomlab 950 is only operated as 
a collimated system.  The results are presented in Figure 3.6 where the relative detection 
efficiency was calculated by dividing the results for each detection position by the 























Figure 3.6:  Relative Efficiency vs. Detector Placement for a Distributed  
Source in a Male Phantom  
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 From these data, it is evident that positioning the detector over the phantom’s 
right lung from either the front or the back would provide the highest count rate.  
However, due to anatomical differences that exist between some of the phantoms and the 
desire to develop standardized models that can be applied to a variety of setups, all the 
simulations were performed with the thyroid probe from the back, right lung position. 
 An additional conclusion can be drawn from the results in Figure 3.6 in regard to 
the collimation of the system.  Since the data are normalized to the highest efficiency, it 
is hard to distinguish the gain in efficiency when the system is placed over the lungs.  
However, the results for the center chest position indicate that a rather substantial 
increase will be obtained by utilizing an uncollimated system, an example of which is 
presented in Figure 3.7.   
 
 
Figure 3.7:  Position of an Uncollimated Detector on a Male Phantom 
 
 Previously, the collimator shielded the detector from most of the lungs as well as 
increased the distance to the source by an additional 15 cm.  Without the collimator 
present, however, there will be an increase in background counts that could adversely 
affect the MDA of the thyroid probe.  
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3.4 Minimum Detectable Activity and Dose Correlations 
 Factors such as the background count rate and the detector count time can greatly 
influence the performance of any in vivo monitoring system.  Therefore, it is necessary to 
establish a detection limit based on the characteristics of the system in question to 
effectively assay radioactivity.  For this work, a number of source distributions and 
detector geometries have been analyzed. The ability to identify low levels of activity for 
each of these setups will be valuable in assessing the capability of the thyroid probe to 
function as a lung monitor. 
 Although many definitions have existed for this limit, the minimum detectable 
activity (MDA) can be best described as the smallest amount of activity that can be 
distinguished from background, given a certain confidence level (Steinmeyer, 1998).  The 
concepts behind this definition are primarily based on the work of Currie, who 
established theoretical levels for detection using Poisson statistics to approximate the 
counting of radioactive samples (Currie, 1968).  A basic equation for determining the 










 B = background counting rate in the ROI (cpm) 
 ε = detection efficiency for a specific nuclide (cpm·nCi-1) 
 tb = counting time for background (min) 
 tc = counting time for measurement (min) 
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 The MDA described by this equation refers to the minimal activity that will be 
detected 95% of the time.  For values below this limit the presence of activity can not be 
accurately measured, but activity above background levels may still exist.  In this study, 
the efficiency will be determined directly from the MCNP output for each of the phantom 
setups and the counting times for the background and measurement are assumed to be the 
same. 
 For the collimated detector models, the background count rates used in the MDA 
calculations were obtained from SC&A’s results.  Since the collimator could not be 
removed in their study (Erdman, 2005), another method was used to obtain an 
uncollimated background.  The Veterans Affairs Medical Clinic in Atlanta uses a similar 
thyroid uptake system with the same NaI crystal size which could be removed from the 
lead collimator housing.  The background count rate obtained from this detector has been 
used in the analysis of the MDA for the uncollimated system. 
 In applying these results to an inhalation model, the retention of the radioactive 
material in the lungs over time must be considered.  After just several hours from intake, 
only a fraction of the inhaled material will still remain in the lungs and will further 
influence the detection ability as time progresses.  It is therefore important to monitor 
internally contaminated victims as quickly as possible following an RDD event. 
 An estimate of the committed dose that would be obtained as a result of 
insufficient detection capabilities can be determined by applying dose conversion 
coefficients (DCCs) to the MDA values.  These dose coefficients utilize radioactive 
decay properties, biokinetic models, as well as inhaled particle size to determine the dose 
over a 50-year period following intake.  To account for the migration of contaminants 
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from the lungs prior to assay, intake retention fractions (IRFs) from NUREG/CR-4884 
have been utilized (Lessard et. al., 1987) and are listed in Tables 4.4 through 4.9.  The 
DCCs presented in Table 3.3 were obtained from Federal Guidance Report No.11 and 
yield the highest committed effective dose for the particle classes listed.  These 
classifications describe the lung clearance times which may be on the order of days (D), 
weeks (W), or years (Y), depending on the radionuclide in question.  For this analysis, 
the inhaled particle sizes are 1-μm activity median aerodynamic diameter (AMAD).   
 
Table 3.3:  Effective Dose Conversion Coefficients for Several Radionuclides of Interest 
Radionuclide Co-60 I-131 Cs-137 Ir-192 Am-241 
Particle 
Class Y D D Y W 
DCC [he(50)] 
(mrem/nCi) 0.219 .0329 .0319 0.0282 444.0 
 
 It should be noted for 241Am that the DCC is at least three orders of magnitude 
larger than the other isotopes being considered.  This value, however, is not the 
controlling dose for the annual limit of intake (ALI) for 241Am.   For this isotope, the ALI 
is based on a 50 rem committed dose equivalent (CDE) to the bone surface (PNNL, 
2003).  In place of the dose coefficient listed in Table 3.3, the CDE of 8.03 rem/nCi has 







4.1 Validation Models 
 The goal of the validation models was to ensure that MCNP could accurately 
reproduce results that were experimentally measured.  For the point source measurements 
in air, 10 million particle histories were tracked and results were obtained with average 
statistical uncertainty of less than 2%.  A comparison of these models is presented in 
Figure 4.1, where the ratio of the measured data to the MCNP results is plotted against 
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Figure 4.1:  Ratio of Measured Values (M) to MCNP Simulations (S) for Point Sources in 
Air at Various Distances from the Detector  
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As can be seen in Figure 4.1, the MCNP results compare well with the measured 
values where the uncertainties in the models have been propagated using standard error 
analysis.  It should be noted that point source measurements for 131I were not made in the 
measurement program and were therefore unavailable for comparison in the air and slab 
models. 
In the acrylic slab phantom measurements, the number of particle histories was 
increased to 50 million to ensure the photon transport through the absorbing medium 
would not result in an increased error value.  The comparison between the MCNP and 
measured results are presented in Figure 4.2 and the statistical uncertainty for these 
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Figure 4.2:  Ratio of Measured Values (M) to MCNP Simulations (S) for Point Sources at 
Various Depths in a Slab Phantom 
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  As indicated in Figure 4.2, the MCNP results were again comparable to the 
measured values.  It should be noted for both the point and acrylic slab models that more 
data points were available for 192Ir than for the other sources.  This is due to the high 
activity of the iridium sample used in SC&A’s measurement program; measurements 
could be made in thicker slab geometries and at distances further from the detector. 
 The final validation model tested the response of the detector to a diffuse source 
of radioactivity, corresponding to the measurements of 131I in Chapter 3.  In this water-
phantom model, 50 million particle histories were tracked, with an average statistical 
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It can be seen in Figure 4.3 that the narrow-sided measurement initially produces 
a higher count rate because more of the source is viewed by the detector.  However, at 
about 45 cm the impact of the collimator is no longer seen as both narrow and broad 
views produce similar results.   
4.2 Detection Efficiency for Human Phantoms 
 In the human phantom models, several different factors have been analyzed along 
with their influence on the thyroid probe’s detection efficiency.  These included different 
source distributions, detector geometries, and tissue thicknesses that would be 
encountered in an RDD event.  In each of the simulations, 100 million particle histories 
were tracked, and the statistical uncertainty ranged from a few tenths to 1%. 
 The data presented in Figures 4.4 through 4.13 are listed according to 
radionuclide and have been grouped based on the collimation and source distribution of 
the model.  For the collimated detectors, the point source in the lung resulted in higher 
efficiencies than did the distributed source for the same total activity.  This can be 
attributed to the collimator limiting the view of the detector.  Not all of the source 
material in the lungs of the phantoms was visible to the NaI crystal in the distributed 
source case, whereas for the point source, the detector was directly in line with the 
source.  However, for larger phantoms, the efficiencies for the point source and 
distributed source approach one another.  It should also be noted that the efficiencies in 
every case decrease from the highest value, obtained in the child, down to the adipose 
man.  The differences among these phantoms are presented in Table 3.2. 
 In the following set of results, a second figure for each radionuclide compares the 
detection efficiencies between a collimated and uncollimated detector.  Depending on the 
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source and the phantom of interest, the efficiency gained in using an uncollimated system 
can range from a factor of 5 for 60Co uniformly distributed in an adipose woman to a 
factor of 12 for 241Am distributed in a child’s lungs.  As mentioned previously, this setup 
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Figure 4.13:  241Am Distributed in Phantom Lungs, Collimated vs. Uncollimated 
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4.3 Minimum Detectable Activity 
 The MDA of the thyroid probe has been calculated for numerous scenarios using 
Equation 3.1.  Tables 4.1 through 4.3 present the results for each of the radionuclides 
examined and illustrate the effects that counting time, source distribution, and detector 
geometry can have on the detectable activity.  The MDA developed by SC&A is also 
analyzed with results presented in Figure 4.14. 
 
Table 4.1:  MDA vs. Counting Time for Distributed Sources in the Lungs of 
Anthropomorphic Phantoms, Using a Collimated Detector 
 
Nuclide Background Phantom Detector Efficiency Counting Time (min) & MDA (nCi) 
 (cpm)  (cpm/nCi) 1 3 5 10 
    AC 1.01 37.4 20.9 16.0 11.2 
   W 0.79 47.9 26.7 20.5 14.3 
Co-60 56 M 0.71 53.5 29.8 22.9 16.0 
   AW 0.46 81.4 45.4 34.8 24.3 
    AM 0.42 89.4 49.9 38.2 26.7 
    AC 0.95 38.4 21.4 16.4 11.5 
   W 0.71 51.2 28.5 21.9 15.3 
I-131 52 M 0.62 58.9 32.9 25.2 17.6 
   AW 0.37 98.5 54.9 42.1 29.4 
    AM 0.33 111 62.1 47.5 33.2 
    AC 0.56 70.5 39.4 30.2 21.1 
   W 0.43 92.6 51.8 39.7 27.8 
Cs-137 62 M 0.37 106 59.2 45.4 31.8 
   AW 0.24 167 93.2 71.4 50.0 
    AM 0.21 187 104.7 80.3 56.2 
    AC 2.86 23.3 13.2 10.1 7.1 
   W 2.14 31.0 17.6 13.5 9.5 
Ir-192 186 M 1.85 35.8 20.3 15.6 11.0 
   AW 1.15 58.0 32.8 25.3 17.8 
    AM 1.01 65.8 37.3 28.7 20.2 
    AC 0.81 37.3 20.7 15.8 11.0 
   W 0.58 52.3 29.0 22.1 15.4 
Am-241 34 M 0.50 60.4 33.4 25.5 17.8 
   AW 0.23 134 73.8 56.4 39.3 
    AM 0.20 149 82.6 63.1 44.0 
Where:        
M – Man W – Woman AC – Androgynous Child 




Table 4.2:  MDA vs. Counting Time for Point Sources in the Lungs of  
Anthropomorphic Phantoms, Using a Collimated Detector 
 
Nuclide Background Phantom Detector Efficiency Counting Time (min) & MDA (nCi) 
 (cpm)   (cpm/nCi) 1 3 5 10 
    AC 1.11 33.9 18.9 14.5 10.1 
   W 0.94 40.2 22.4 17.2 12.0 
Co-60 56 M 0.93 40.5 22.6 17.3 12.1 
   AW 0.52 72.4 40.4 31.0 21.7 
    AM 0.51 73.9 41.2 31.6 22.1 
    AC 1.15 31.8 17.7 13.6 9.5 
   W 0.95 38.5 21.5 16.4 11.5 
I-131 52 M 0.94 38.9 21.7 16.6 11.6 
   AW 0.44 83.7 46.7 35.7 25.0 
    AM 0.43 84.7 47.2 36.1 25.3 
    AC 0.65 60.7 33.9 26.0 18.2 
   W 0.54 72.7 40.6 31.2 21.8 
Cs-137 62 M 0.54 73.2 40.9 31.4 22.0 
   AW 0.27 145 80.8 61.9 43.3 
    AM 0.27 147 82.0 62.9 44.0 
    AC 3.47 19.2 10.8 8.4 5.9 
   W 2.85 23.3 13.2 10.1 7.1 
Ir-192 186 M 2.80 23.7 13.4 10.3 7.3 
   AW 1.35 49.1 27.8 21.4 15.1 
    AM 1.32 50.3 28.5 21.9 15.4 
    AC 0.95 31.7 17.6 13.4 9.4 
   W 0.73 41.4 22.9 17.5 12.2 
Am-241 34 M 0.70 43.0 23.8 18.2 12.7 
   AW 0.25 119 66.0 50.4 35.2 
    AM 0.24 123 68.2 52.1 36.3 
Where:        
M – Man W – Woman AC – Androgynous Child 











 Table 4.3:  MDA vs. Counting Time for Distributed Sources in the Lungs of 
Anthropomorphic Phantoms, Using an Uncollimated Detector 
 
Nuclide Background Phantom Detector Efficiency Counting Time (min) & MDA (nCi) 
  (cpm)   (cpm/nCi) 1 3 5 10 
    AC 8.03 11.9 6.8 5.2 3.7 
   W 5.53 17.3 9.8 7.6 5.3 
Co-60 395 M 5.01 19.0 10.8 8.4 5.9 
   AW 2.36 40.4 23.0 17.8 12.5 
    AM 2.16 44.2 25.2 19.4 13.7 
    AC 8.90 16.2 9.3 7.2 5.1 
   W 5.90 24.5 14.0 10.8 7.6 
I-131 923 M 5.37 26.9 15.4 11.9 8.4 
   AW 2.14 67.6 38.7 29.9 21.1 
    AM 1.95 73.9 42.3 32.7 23.0 
    AC 4.96 20.5 11.7 9.0 6.3 
   W 3.33 30.5 17.4 13.4 9.4 
Cs-137 449 M 3.03 33.5 19.1 14.7 10.4 
   AW 1.30 78.2 44.6 34.4 24.2 
    AM 1.18 86.2 49.1 37.9 26.7 
    AC 27.02 8.9 5.1 4.0 2.8 
   W 18.30 13.2 7.6 5.9 4.1 
Ir-192 2633 M 16.58 14.6 8.4 6.5 4.6 
   AW 7.25 33.3 19.2 14.8 10.5 
    AM 6.59 36.7 21.1 16.3 11.5 
    AC 9.81 19.0 10.9 8.4 5.9 
   W 6.52 28.6 16.4 12.7 9.0 
Am-241 1559 M 5.94 31.4 18.0 13.9 9.8 
   AW 2.22 84.2 48.3 37.3 26.3 
    AM 2.02 92.2 52.8 40.8 28.8 
Where:        
M – Man W – Woman AC – Androgynous Child 
AM – Adipose Man AW – Adipose Woman  
 
 Following from Equation 3.1, it is evident that an increase in the counting time 
will ultimately lower the MDA in every scenario.  It can also be seen that the 
androgynous child phantom consistently yields the lowest MDA, as would be expected 
with the smaller chest thickness and distance to center lung.  In Table 4.3 it has been 
shown that the effect of the increased background for the uncollimated detector was 
outweighed by the increased detection efficiency that came from the relocation of the NaI 
crystal closer to the phantom’s back.  The results for an uncollimated thyroid probe 
  36
 
indicate that it would provide the lowest MDA, but the influence of varying background 
count rates has not be analyzed. 
4.3.1 Comparison to SC&A Model 
 In an effort to compare their results to an actual RDD scenario, SC&A correlated 
the measurements in their study to a distributed source in a lung (Anigstein et al., 2005).  
The MDA values obtained have been compared to the MCNP results for the collimated 
detector with distributed sources in the lungs of a male phantom.  The results are 
presented in Figure 4.14, where the MDA ratio has been computed by dividing the SC&A 


























Figure 4.14:  Ratio of Measured Values (M) to MCNP Simulations (S) for the MDA of 
Distributed Sources in the Lungs 
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 From Figure 4.14, it can be seen that the method used in the measurement 
program overestimates the sensitivity of the detection system.  In their analysis, SC&A 
evaluated the mass thickness of a theoretical phantom’s chest wall and lung tissue to 
determine the number of acrylic slabs that would have a similar attenuation.  To account 
for a distributed source in the phantom’s lung, the results for 131I in the water-filled jug 
were applied to the source-detector distance correlation.  A correction factor was 
established from these data and was applied to the MDA values for the sources presented 
in Figure 4.14 to estimate the values for a distributed source (Anigstein et al., 2005).   
The difference between SC&A’s results and the MCNP values is particularly 
evident for the sources with lower energy photons, where a simple correlation will not 
effectively represent their transport through tissue.  The only source for which values 
were somewhat similar for both MCNP and the measurement study was 60Co, whose high 
energy gammas will not be greatly attenuated in either model.  131I was not available for 
comparison since SC&A did not have point source measurements for this radioisotope.  It 
can be concluded that the MCNP simulations better represent source and phantom 
geometries that would be expected in an inhalation event and can therefore effectively 
predict the response of the thyroid counter to a variety of different scenarios.  
4.4 Dose Calculations 
 The calculation of the committed dose has been performed for the radionuclides 
used in this work in regard to the male phantom.  Since the amount of material in the 
lungs will decrease from the time of intake to the time of measurement, there is a 
possibility that only values below the MDA will be present when the person’s lung is 
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assayed.  Therefore, retention factors were used to determine activity on intake that must 




                                                  [4.1] 
 
where: 
 MDI = minimum detectable intake 
 MDA = minimum detectable activity (detection system) 
 IRF(t) = intake retention fraction (varies with time) 
 
 The dose coefficients from Table 3.3 were then applied to these intake values to 
determine the minimum detectable dose (MDD) that would be incurred from the initial 
inhaled activity: 
 
MDD = MDI DCC⋅                                              [4.2] 
 
  The results that follow are given in measurement time-steps that range from a few 
hours to seven days after intake.  The data are also based off the 10-minute MDAs 
presented in the previous section for the collimated and uncollimated detectors and for 
both source geometries.  As previously mentioned for 241Am, the bone surface dose, not 
the effective dose, will be its limiting factor.  However, for comparison purposes the 
committed effective dose has also been calculated for 241Am.  It should be noted that 
Tables 4.8 and 4.9 have dose values in rem whereas the other tables are in mrem. 
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Table 4.4:  MDI and MDD for 60Co in a Male Phantom 




(Point Source) Uncollimated 







(nCi) (mrem) (nCi) (mrem) (nCi) (mrem) 
        
0.1 0.304 52.6 11.5 39.8 8.7 19.4 4.2 
        
0.3 0.270 59.3 13.0 44.8 9.8 21.8 4.8 
        
0.5 0.247 64.8 14.2 49.0 10.7 23.8 5.2 
        
0.7 0.231 69.3 15.2 52.4 11.5 25.5 5.6 
        
1.0 0.213 75.1 16.4 56.8 12.4 27.6 6.1 
        
3.0 0.164 97.5 21.4 73.8 16.2 35.9 7.9 
        
7.0 0.149 107 23.5 81.2 17.8 39.5 8.7 
        
Basis:10-minute 
MDA (nCi) 16.0 12.1 5.9 
 
Table 4.5:  MDI and MDD for 131I in a Male Phantom 




(Point Source) Uncollimated 







(nCi) (mrem) (nCi) (mrem) (nCi) (mrem) 
        
0.1 0.224 78.5 2.6 51.8 1.7 37.4 1.2 
        
0.3 0.175 100 3.3 66.3 2.2 47.9 1.6 
        
0.5 0.137 128 4.2 84.7 2.8 61.2 2.0 
        
0.7 0.106 166 5.5 109 3.6 79.1 2.6 
        
1.0 0.073 241 7.9 159 5.2 115 3.8 
        
3.0 0.006 3193 105 2106 69.3 1521 50.0 
        
7.0 2.45E-05 7.18E+05 2.36E+04 4.74E+05 1.56E+04 3.42E+05 1.13E+04
        
Basis:10-minute 
MDA (nCi) 17.6 11.6 8.4 
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Table 4.6:  MDI and MDD for 137Cs in a Male Phantom 




(Point Source) Uncollimated 







(nCi) (mrem) (nCi) (mrem) (nCi) (mrem) 
        
0.1 0.226 141 4.5 97.1 3.1 45.9 1.5 
        
0.3 0.179 177 5.7 123 3.9 57.9 1.8 
        
0.5 0.143 222 7.1 154 4.9 72.5 2.3 
        
0.7 0.113 281 9.0 194 6.2 91.7 2.9 
        
1.0 0.080 398 12.7 275 8.8 130 4.1 
        
3.0 0.007 4454 142 3079 98.2 1454 46.4 
        
7.0 4.47E-05 7.10E+05 2.27E+04 4.91E+05 1.57E+04 2.32E+05 7.40E+03
        
Basis:10-minute 
MDA (nCi) 31.8 22.0 10.4 
 
Table 4.7:  MDI and MDD for 192Ir in a Male Phantom 




(Point Source) Uncollimated 







(nCi) (mrem) (nCi) (mrem) (nCi) (mrem) 
        
0.1 0.304 36.1 1.0 23.9 0.7 15.0 0.4 
        
0.3 0.269 40.8 1.2 27.0 0.8 17.0 0.5 
        
0.5 0.246 44.6 1.3 29.5 0.8 18.6 0.5 
        
0.7 0.229 47.9 1.4 31.7 0.9 20.0 0.6 
        
1.0 0.211 52.0 1.5 34.4 1.0 21.7 0.6 
        
3.0 0.160 68.6 1.9 45.4 1.3 28.6 0.8 
        
7.0 0.140 78.4 2.2 51.9 1.5 32.6 0.9 
        
Basis:10-minute 
MDA (nCi) 11.0 7.3 4.6 
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Table 4.8:  MDI and MDD for 241Am in a Male Phantom, Based on CED 




(Point Source) Uncollimated 







(nCi) (rem) (nCi) (rem) (nCi) (rem) 
        
0.1 0.276 64.5 28.7 45.9 20.4 35.6 15.8 
        
0.3 0.256 69.6 30.9 49.4 22.0 38.4 17.0 
        
0.5 0.240 74.2 33.0 52.7 23.4 40.9 18.2 
        
0.7 0.227 78.5 34.8 55.8 24.8 43.3 19.2 
        
1.0 0.211 84.4 37.5 60.0 26.6 46.5 20.7 
        
3.0 0.160 111 49.4 79.1 35.1 61.4 27.3 
        
7.0 0.138 129 57.3 91.7 40.7 71.2 31.6 
        
Basis:10-minute 
MDA (nCi) 17.8 12.7 9.8 
 
Table 4.9:  MDI and MDD for 241Am in a Male Phantom, Based on CDE 




(Point Source) Uncollimated 







(nCi) (rem) (nCi) (rem) (nCi) (rem) 
        
0.1 0.276 64.5 518 45.9 368 35.6 286 
        
0.3 0.256 69.6 559 49.4 397 38.4 308 
        
0.5 0.240 74.2 596 52.7 424 40.9 329 
        
0.7 0.227 78.5 630 55.8 448 43.3 347 
        
1.0 0.211 84.4 678 60.0 482 46.5 374 
        
3.0 0.160 111 894 79.1 635 61.4 493 
        
7.0 0.138 129 1036 91.7 737 71.2 571 
        
Basis:10-minute 
MDA (nCi) 17.8 12.7 9.8 
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 There are several results of particular interest that can be obtained from these 
tables.  For 131I and 137Cs, Tables 4.5 and 4.6, respectively, the lung retention fractions 
decrease rather rapidly from one to seven days after intake, corresponding to large 
increases in the MDI and MDD for these sources.  In a scenario involving the inhalation 
of either of these radionuclides, it would be beneficial to assay people within the first 
twenty-four hours to increase the chance of detection.   
 Of even greater concern are the results for 241Am, presented in Tables 4.8 and 4.9.  
After two-and-a-half hours following intake, the collimated thyroid counter would only 
detect values that would result in a CED around 29 rem and a committed bone surface 
dose of approximately 520 rem.  If an uncollimated probe were available, these values 
could be greatly reduced, as indicated in the above tables.  However, these results 
indicate that this detection system may not be adequate to effectively assay this 






 The intent of this work was to determine the feasibility of a thyroid uptake 
counter for monitoring lung contamination following a radiological incident that involves 
the public.  Using MCNP5 to create various human phantom models, it was found that 
this detection system can be used to determine the presence of several important 
radionuclides in the lungs.  
 Minimum detectable activity limits for this detection system range from 
approximately 3 nCi to 0.2 μCi, depending on the characteristics of the source, detector, 
and the measurement environment.  The committed dose corresponding to the MDA of 
the detection system can be determined from this information using inhalation dose 
conversion coefficients and intake retention fractions.  The effective dose corresponding 
to the MDA for 241Am is rather large and depending on the dose threshold for treatment, 
may not be adequate to triage 241Am lung burdens of concern. 
 The analysis for an uncollimated detector system was performed and revealed that 
it was on average about eight times more efficient than a collimated system, despite the 
increased background count rate.  In relation to measured data for the Atomlab 950, the 
MCNP results for a more anthropomorphic representation of the human body indicate 
that the capabilities of the thyroid counter can be overestimated using point sources of 
radiation.   
In summary, this detection system can be effectively used in an RDD event to 
assess victims for triage, with the possible exception of an event involving 241Am.  A 
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variety of parameters should be considered in any evaluation, such as the collimation of 
the detector, expected source geometry, mass of the individual, background count rate, 






 The methods used in this work were designed to establish the feasibility of 
detecting inhaled contamination with a thyroid probe.  However, several simplifications 
were made in the MCNP models that could be improved upon in future studies to better 
represent the effects from an RDD event.  For example, despite entering the body through 
airways, the concentration of isotopes may have migrated to other organs and could be 
detected by an uncollimated detector.  Metabolic modeling could be performed to obtain 
material distributions in the body that may influence the detector’s response at various 
period of time after intake. 
 Additional analysis can be performed on the uncollimated detector geometry.  
Although the efficiency of the detection system is greatly improved by using an 
uncollimated system, the effect of a varying background counting rate has not been 
analyzed.  It would be beneficial to establish criteria where an uncollimated detector 
would greatly outperform the collimated system. 
 MCNP modeling could also be extended to represent people of different ages, 
including infants, who may be contaminated in an RDD event.  The use of retention 
factors and dose conversion coefficients applicable to these models would also be of 
benefit.   















C Point Source in Air with Detector System, Co-60 Case 
C Cell Cards 
130 10 -2.70 -13 14 imp:p=1 $Al around NaI 
140 4 -3.67 -14 imp:p=1 $NaI detector 
150 5 -11.35 -15 13 16 19 imp:p=1 $Lead 1 
160 3 -0.00129 -16 -15 13 19 imp:p=1 $Air cone 
190 3 -0.00129 -19 13 imp:p=1 $Air behind NaI 
998 3 -0.00129 15 -99 imp:p=1 $Air in system 
999 0 99 imp:p=0 $Outside Universe 
 
C Surface Cards 
13 rcc 15.24 0 0 5.18 0 0 2.59 $Al around NaI 
14 rcc 15.29 0 0 5.08 0 0 2.54 $NaI detector 
15 rcc 0 0 0 27.99 0 0 4.65175 $Lead collimator and housing 
16 k/x 33.997 0 0 0.0183378 -1 $Collimator hole 
19 rcc 20.37 0 0 7.62 0 0 2.54 $Gap behind NaI 
99 rpp -500 500 -100 100 -100 100 $Universe Box 
 
C Data Cards 
C Material Cards 
m3 7014 .755267 8016 .231781 6000 .000125 18000 .012827 $Air 
m4 11000 .5 53000 .5 $NaI 
m5 82000 1 $Lead 
m10 13000 1 $Aluminum 
C Source Definition 
sdef pos=-50 0 0 erg=d1 par=2 
si1 l 1.17 1.33 $Co-60 
sp1 0.9986 0.9998 
f8:p 140 
f18:p 140 
ft18 GEB -0.0060465 0.06261 0.015694 
e18 0 1024i 2.5 
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C Acrylic Slab Phantom and Detector System, Ir-192 Case 
C Cell Cards 
100 1 -1.19 -10 11 imp:p=1 $Source Slab 
110 3 -0.001293 -11 imp:p=1 $Air Space in Slab 
120 1 -1.19 -12 imp:p=1 $Other Slabs 
130 10 -2.70 -13 14 imp:p=1 $Al around NaI 
140 4 -3.67 -14 imp:p=1 $NaI detector 
150 5 -11.35 -15 13 16 19 imp:p=1 $Lead 1 
160 3 -0.001293 -16 -15 13 19 imp:p=1 $Air cone 
190 3 -0.001293 -19 13 imp:p=1 $Air behind NaI 
998 3 -0.001293 15 10 12 -99 imp:p=1 $Air in system 
999 0 99 imp:p=0 $Outside Universe 
 
C Surface Cards 
10 rpp -26.191 -23.81 -14.9225 14.9225 -14.9225 14.9225 $Slab with Source 
11 rcc -24.762 0 0 .952 0 0 1.42875 $Air space in slab 
12 rpp -23.81 0 -14.9225 14.9225 -14.9225 14.9225 $Other Slabs 
13 rcc 15.24 0 0 5.18 0 0 2.59 $Al around NaI 
14 rcc 15.29 0 0 5.08 0 0 2.54 $NaI detector 
15 rcc 0 0 0 27.99 0 0 4.65175 $Lead collimator and housing 
16 k/x 33.997 0 0 0.0183378 -1 $Collimator hole 
19 rcc 20.37 0 0 7.62 0 0 2.54 $Gap behind NaI 
99 rpp -500 500 -100 100 -100 100 $Universe Box 
 
C Data Cards 
C Material Cards 
m1 6000 .3333 8016 .1333 1001 .5334 $Lucite 
m3 7014 .755267 8016 .231781 6000 .000125 18000 .012827 $Air 
m4 11000 .5 53000 .5 $NaI 
m5 82000 1 $Lead 
m10 13000 1 $Aluminum 
C Source Definition 
sdef pos=-24.06 0 0 erg=d1 par=2  
si1 l .296 .308 .317 .468 .485 .589 .604 .612 $Ir-192  
sp1 .290 .297 .828 .478 .0316 .0452 .0818 .0533 
f8:p 140 
f18:p 140 
ft18 GEB -0.0060465 0.06261 0.015694 
e18 0 1024i 2.5 
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C Water-Filled Phantom and Detector System, ~100cm Case 
C Cell Cards 
1 1 -1.19 -1 imp:p=1  
2 1 -1.19 -2 imp:p=1 
3 1 -1.19 -3 imp:p=1 
4 1 -1.19 -4 imp:p=1 
5 1 -1.19 -5 imp:p=1 
6 1 -1.19 -6 imp:p=1 
7 6 -1 -7 imp:p=1 $Water in system 
130 10 -2.70 -13 14 imp:p=1 $Al around NaI 
140 4 -3.67 -14 imp:p=1 $NaI detector 
150 5 -11.35 -15 13 16 19 imp:p=1 $Lead 1 
160 3 -0.00129 -16 -15 13 19 imp:p=1 $Air cone 
190 3 -0.00129 -19 13 imp:p=1 $Air behind NaI 
998 3 -0.00129 1 2 3 4 5 6 7 15 -99 imp:p=1 $Air in system 
999 0 99 imp:p=0 $Outside Universe 
 
C Surface Cards 
1  rpp -16 0 -11.75 11.75 14.8 15 $Top of Container 
2  rpp -16 0 -11.75 11.75 -15 -14.8 $Bottom of Container 
3  rpp -16 0 -11.75 -11.55 -14.8 14.8 $Narrow side 1 
4  rpp -16 0 11.55 11.75 -14.8 14.8 $Narrow side 2 
5  rpp -0.2 0 -11.55 11.55 -14.8 14.8 $Front broad 
6  rpp -16 -15.8 -11.55 11.55 -14.8 14.8 $Rear broad 
7  rpp -15.8 -0.2 -11.55 11.55 -14.8 13.2 $Water 
13 rcc 105.24 0 -.8 5.18 0 0 2.59 $Al around NaI 
14 rcc 105.29 0 -.8 5.08 0 0 2.54 $NaI detector 
15 rcc 90 0 -.8 27.99 0 0 4.65175 $Lead collimator and housing 
16 k/x 123.997 0 -.8 0.0183378 -1 $Collimator hole 
19 rcc 110.37 0 -.8 7.62 0 0 2.54 $Gap behind NaI 
99 rpp -500 500 -100 100 -100 100 $Universe Box 
 
C Data Cards 
C Material Cards 
m1 6000 .3333 8016 .1333 1001 .5334 $Lucite 
m3 7014 .755267 8016 .231781 6000 .000125 18000 .012827 $Air 
m4 11000 .5 53000 .5 $NaI 
m5 82000 1 $Lead 
m6 1000 .6666 8016 .3334 $Water 
m10 13000 1 $Aluminum 
C Source Definition 
sdef erg=d1 x=d2 y=d3 z=d4 par=2 cel=7  
si1 l .3645 .637 $I-131  
sp1 0.812 0.0727 
si2 -15.8 -0.2 
sp2 0 1 
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si3 -11.55 11.55 
sp3 0 1 
si4 -14.8 13.2 
sp4 0 1 
f8:p 140 
f18:p 140 
ft18 GEB -0.0060465 0.06261 0.015694 
e18 0 1024i 2.5 
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C Male Phantom at  21.0 Years 
C Since this input file is licensed for the user only, only the headings that describe the      
C body parts and organs that were included in the model have been included in this         
C Appendix.  The detector geometry and source definitions that were combined with this 
C input deck are also included.  
c +++++++++++++++++++++++++++++++++++++++++ 
c    File Prepared by Body Builder 
c    CopyRight 1996-2004, White Rock Science 
c    This input file is for the use of 
c    BodyBuilder License holder only. 
c    Distribution is Prohibited. 
c +++++++++++++++++++++++++++++++++++++++++ 
c ++++++++++++++++++++++++++++++++++++++++++++++ 
c           CELLS 
c ++++++++++++++++++++++++++++++++++++++++++++++ 
c         LEG BONES 
c         ARM BONES 
c         PELVIS 
c         SPINE 
c         SKULL & FACE 
c         RIBS 
c         CLAVICLES 
c         SCAPULAE 
c         ADRENALS 
c         BRAIN 
c         GALL BLADDER 
c         ESOPHAGUS 
c         STOMACH 
c         SMALL INTESTINE 
c         ASCENDING COLON 
c         TRANSVERSE COLON 
c         DESCENDING COLON 
c         SIGMOID COLON 
c         HEART 
c         KIDNEYS 
c         LIVER 
c         LUNGS 
c         PANCREAS 
c         SPLEEN 
c         TESTICLES 
c         THYMUS 
c         THYROID 
c         URINARY BLADDER 
c         PENIS & SCROTUM 
c         SKIN 
c           Trunk Skin 
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c         Penis & Scrotum Skin 
c        Legs Skin 
c            HEAD 
c            NECK 
c         OUTER TRUNK---ARMS & SCAPULAE 
c         UPPER TRUNK---ABOVE RIBS 
c         UPPER RIB CAGE 
c         LOWER RIB CAGE 
c         HIGH CHEST ORGANS 
c         CHEST---LIVER LEVEL 
c         LOWER TRUNK 
c        LEGS 
c         SURROUNDING AIR 
c            air            OUTSIDE of NECK 
c 
c  Detector setup 
602 5 -3.67 -800 imp:p=1 $NaI detector 
603 6 -11.35 -801 804 802 805 imp:p=1 $Lead 1 
604 4 -0.001293 -801 -802 800 804 805 imp:p=1 $Air cone 
605 10 -2.70 -804 800 imp:p=1 $Al around NaI 
608 4 -0.001293 -805 804 imp:p=1 $Air behind NaI 
c         VOID 
700   0               600 
             imp:p =0 
  
c ++++++++++++++++++++++++++++++++++++++++++++++ 



















m5 11000 .5 53000 .5 $NaI 
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m6 82000 1 $Lead 
m10 13000 1 $Aluminum 
C Source Definition 
sdef erg=d1 x=d2 y=d3 z=d4 par=2 cel=330  
c si1 l 1.17 1.33 $Co-60 
c sp1 0.9986 0.9998 
C si1 l 0.6617 $Cs-137 
C sp1 0.851 
C si1 l 0.0595 $Am-241  
C sp1 0.359 
C si1 l .3645 .637 $I-131  
C sp1 0.812 0.0727 
si1 l .296 .308 .317 .468 .485 .589 .604 .612 $Ir-192  
sp1 .290 .297 .828 .478 .0316 .0452 .0818 .0533 
si2 -13.7 13.7 
sp2 0 1 
si3 -7.6 7.6 
sp3 0 1 
si4 43.4 67.6 
sp4 0 1 
f8:p 602 
f18:p 602 
ft18 GEB -0.0060465 0.06261 0.015694 
C f28:p 140 
C e28 0 .040 .073 1 2.5 $Am-241 
C e8 0 .015 .075 1 2.5 
e18 0 1024i 2.5 
c e8 0 .997 1.533 2 2.5 $Co-60 
C e8 0 .561 .761 1 2.5 $ Cs-137 
e8 0 .250 .703 1 2.5 $ Ir-192 
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